Cheyne Capital Management (UK) LLP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 114 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$404,000
-69.0%
70,000
-56.2%
0.19%
-55.2%
Q2 2015$1,305,000
+219.9%
160,000
+220.0%
0.42%
+330.6%
Q1 2015$408,00050,0000.10%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Round Table Services, LLC 129,500$1,207,0000.72%
STONERIDGE INVESTMENT PARTNERS LLC 252,376$2,352,0000.34%
Bellevue Group AG 155,000$1,445,0000.26%
WASATCH ADVISORS LP 1,861,553$17,350,0000.26%
Blue Clay Capital Management, LLC 13,000$121,0000.14%
Virtus ETF Advisers LLC 24,058$224,0000.11%
EMERALD ADVISERS, LLC 203,737$1,899,0000.08%
Vident Investment Advisory, LLC 63,383$591,0000.08%
Thomas J. Herzfeld Advisors, Inc. 15,000$140,0000.08%
GSA CAPITAL PARTNERS LLP 94,400$880,0000.05%
View complete list of INOVIO PHARMACEUTICALS INC shareholders